Skip to navigation Skip to content
  • Woodruff
  • Business
  • Health Sciences
  • Law
  • Rose
  • Oxford College
  • Theology
  • Schools
    • Undergraduate

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing

      Community

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing
    • Graduate

      • Business School
      • Graduate School
      • School of Law
      • School of Medicine
      • School of Nursing
      • School of Public Health
      • School of Theology
  • Libraries
    • Libraries

      • Robert W. Woodruff
      • Business
      • Chemistry
      • Health Sciences
      • Law
      • MARBL
      • Music & Media
      • Oxford College
      • Theology
    • Library Tools

      • Course Reserves
      • Databases
      • Digital Scholarship (ECDS)
      • discoverE
      • eJournals
      • Electronic Dissertations
      • EmoryFindingAids
      • EUCLID
      • ILLiad
      • OpenEmory
      • Research Guides
  • Resources
    • Resources

      • Administrative Offices
      • Emory Healthcare
      • Academic Calendars
      • Bookstore
      • Campus Maps
      • Shuttles and Parking
      • Athletics: Emory Eagles
      • Arts at Emory
      • Michael C. Carlos Museum
      • Emory News Center
      • Emory Report
    • Resources

      • Emergency Contacts
      • Information Technology (IT)
      • Outlook Web Access
      • Office 365
      • Blackboard
      • OPUS
      • PeopleSoft Financials: Compass
      • Careers
      • Human Resources
      • Emory Alumni Association
  • Browse
    • Works by Author
    • Works by Journal
    • Works by Subject
  • For Authors
    • How to Submit
    • Deposit Advice
    • Deposit Instructions
    • Author Rights
    • FAQ
    • Emory Open Access Policy
    • Open Access Fund
  • About OpenEmory
    • About OpenEmory
    • About Us
    • Citing Articles
    • Contact Us
    • Privacy Policy
    • Terms of Use
 
Contact Us

Filter Results:

Year

  • 2014 (168)
  • 2020 (168)
  • 2019 (163)
  • 2018 (162)
  • 2021 (156)
  • 2016 (152)
  • 2017 (146)
  • 2022 (132)
  • 2013 (123)
  • 2012 (90)
  • 2015 (80)
  • 2023 (53)
  • 2011 (32)
  • 2010 (18)
  • 2009 (15)
  • 2008 (13)
  • 2007 (12)
  • 2006 (10)
  • 2001 (8)
  • 1999 (5)
  • 1997 (4)
  • 2002 (4)
  • 2003 (4)
  • 1994 (3)
  • 1998 (3)
  • 2000 (3)
  • 2005 (3)
  • 1995 (2)
  • 1996 (2)
  • 2004 (2)

Author

  • Seyfried, Nicholas (43)
  • Bassell, Gary (41)
  • Ye, Keqiang (31)
  • Corbett, Anita (25)
  • Fu, Haian (25)
  • Kim, Baek (25)
  • Benian, Guy (22)
  • Levey, Allan (22)
  • Ortlund, Eric (22)
  • Miller, Andrew (20)
  • Dammer, Eric (18)
  • Sarafianos, Stefan (18)
  • Duong, Duc M. (17)
  • Gearing, Marla (17)
  • Cheng, Xiaodong (16)
  • Faundez, Victor (16)
  • Jin, Peng (16)
  • Du, Yuhong (15)
  • Anderson, Larry (14)
  • Khuri, Fadlo (14)
  • Li, Xiao-Jiang (14)
  • Moore, Martin (14)
  • Schinazi, Raymond (14)
  • Traynelis, Stephen (14)
  • Felger, Jennifer (13)
  • Hall, Randy (13)
  • Kahn, Richard (13)
  • Lah, James (13)
  • Liu, Xia (13)
  • Lonial, Sagar (13)
  • Owonikoko, Taofeek (13)
  • Smith, Yoland (13)
  • Warren, Stephen (13)
  • Arbiser, Jack (12)
  • Jo, Hanjoong (12)
  • Melikian, Gregory (12)
  • Qadota, Hiroshi (12)
  • Quyyumi, Arshed (12)
  • Conn, Graeme (11)
  • Cummings, Richard (11)
  • Deng, Xingming (11)
  • Hunter, Eric (11)
  • Jones, Dean (11)
  • Kirby, Karen (11)
  • Ono, Shoichiro (11)
  • Qin, Zhaohui (11)
  • Ramalingam, Suresh (11)
  • Shafer, William (11)
  • Vaccarino, Viola (11)
  • Alonso, Alvaro (10)
  • Boise, Lawrence (10)
  • Caspary, Tamara (10)
  • Kahn, Richard A (10)
  • Koval, Michael (10)
  • Li, Lian (10)
  • Li, Shihua (10)
  • Ressler, Kerry (10)
  • Selvaraj, Periasamy (10)
  • Singh, Balwan (10)
  • Suchdev, Parminder (10)
  • Tedbury, Philip (10)
  • Weinshenker, David (10)
  • Yu, David (10)
  • Zhang, Xing (10)
  • Galinski, Mary (9)
  • Gross, Christina (9)
  • Haroon, Ebrahim (9)
  • Kang, Sang-Moo (9)
  • Liang, Bo (9)
  • Marin, Mariana (9)
  • Reines, Daniel (9)
  • Salaita, Khalid (9)
  • Smith, David (9)
  • Yu, Shan Ping (9)
  • Zhang, Zhentao (9)
  • Chin, Lih-Shen (8)
  • Compans, Richard W (8)
  • Duong, Duc M (8)
  • Eaton, Douglas (8)
  • Feng, Yue (8)
  • Ko, Yi-An (8)
  • Levey, Allan I (8)
  • Li, Yujing (8)
  • McBride, Shonna (8)
  • Plemper, Richard (8)
  • Quyyumi, Arshed Ali (8)
  • Smith, Alicia (8)
  • Spearman, Paul (8)
  • Sun, Shi-Yong (8)
  • Van Meir, Erwin (8)
  • Wen, Zhexing (8)
  • Yi, Hong (8)
  • Banerjee, Ayan (7)
  • Bommireddy, Ramireddy (7)
  • Doetsch, Paul (7)
  • Griendling, Kathy (7)
  • Gutekunst, Claire-Anne (7)
  • Hammadah, Muhammad (7)
  • He, Peijian (7)
  • Horton, John (7)

Subject

  • Biology, Cell (317)
  • Health Sciences, Medicine and Surgery (311)
  • Chemistry, Biochemistry (306)
  • Health Sciences, Immunology (260)
  • Health Sciences, Oncology (251)
  • Biology, Neuroscience (223)
  • Biology, Genetics (220)
  • Health Sciences, Pathology (198)
  • Biology, Molecular (154)
  • Biology, Microbiology (152)
  • Health Sciences, Pharmacology (150)
  • Biology, Virology (111)
  • Engineering, Biomedical (102)
  • Health Sciences, General (101)
  • Health Sciences, Public Health (99)
  • Health Sciences, Epidemiology (80)
  • Biology, Biostatistics (45)
  • Biology, Physiology (44)
  • Health Sciences, Nutrition (33)
  • Chemistry, General (30)
  • Biology, General (25)
  • Health Sciences, Obstetrics and Gynecology (23)
  • Health Sciences, Pharmacy (23)
  • Health Sciences, Radiology (23)
  • Psychology, Behavioral (21)
  • Chemistry, Pharmaceutical (20)
  • Health Sciences, Mental Health (20)
  • Health Sciences, Opthamology (17)
  • Environmental Sciences (16)
  • Health Sciences, Human Development (15)
  • Health Sciences, Health Care Management (14)
  • Psychology, Cognitive (14)
  • Biophysics, Medical (11)
  • Psychology, Clinical (11)
  • Biology, Bioinformatics (10)
  • Health Sciences, Rehabilitation and Therapy (9)
  • Health Sciences, Toxicology (9)
  • Chemistry, Physical (8)
  • Biology, Anatomy (7)
  • Biology, Animal Physiology (6)
  • Biology, Parasitology (6)
  • Physics, General (6)
  • Engineering, Chemical (5)
  • Health Sciences, Nursing (5)
  • Psychology, Psychobiology (5)
  • Biology, Zoology (4)
  • Biophysics, General (4)
  • Gerontology (4)
  • Physics, Molecular (4)
  • Psychology, Physiological (4)
  • Biology, Ecology (3)
  • Biology, Veterinary Science (3)
  • Education, Technology (3)
  • Engineering, Materials Science (3)
  • Engineering, Mechanical (3)
  • Health Sciences, Dentistry (3)
  • Psychology, Experimental (3)
  • Biology, Entomology (2)
  • Biology, Radiation (2)
  • Chemistry, Organic (2)
  • Chemistry, Radiation (2)
  • Computer Science (2)
  • Engineering, Electronics and Electrical (2)
  • Engineering, Environmental (2)
  • Mathematics (2)
  • Psychology, General (2)
  • Agriculture, Animal Pathology (1)
  • Agriculture, Plant Culture (1)
  • Anthropology, Medical and Forensic (1)
  • Chemistry, Analytical (1)
  • Chemistry, Inorganic (1)
  • Chemistry, Nuclear (1)
  • Economics, General (1)
  • Engineering, General (1)
  • Gender Studies (1)
  • Health Sciences, Audiology (1)
  • Health Sciences, Occupational Health and Safety (1)
  • Physics, Optics (1)
  • Physics, Radiation (1)
  • Psychology, Developmental (1)
  • Psychology, Psychometrics (1)
  • Religion, Philosophy of (1)
  • Sociology, Ethnic and Racial Studies (1)
  • Sociology, Public and Social Welfare (1)

Journal

  • PLoS ONE (71)
  • Journal of Biological Chemistry (59)
  • Journal of Virology (29)
  • Proceedings of the National Academy of Sciences (29)
  • Nature Communications (28)
  • Journal of Cell Biology (27)
  • Journal of Neuroscience Nursing (27)
  • Scientific Reports (24)
  • Molecular Biology of the Cell (20)
  • NATURE COMMUNICATIONS (17)
  • PLoS Pathogens (17)
  • JOURNAL OF BIOLOGICAL CHEMISTRY (14)
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (14)
  • Journal of Neuroscience (13)
  • Nucleic Acids Research (13)
  • Cell Reports (12)
  • Oncotarget (12)
  • SCIENCE ADVANCES (12)
  • VIRUSES-BASEL (12)
  • Virology (11)
  • INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (10)
  • Molecular Cell (10)
  • American Journal of Transplantation (9)
  • FRONTIERS IN IMMUNOLOGY (9)
  • Infection and Immunity (9)
  • Nature (9)
  • PLoS Genetics (9)
  • CELL REPORTS (8)
  • Cancer (8)
  • Journal of Clinical Investigation (8)
  • PLOS ONE (8)
  • Acta Biomaterialia (7)
  • Brain, Behavior, and Immunity (7)
  • Journal of Proteome Research (7)
  • Nature Medicine (7)
  • SCIENTIFIC REPORTS (7)
  • Viruses (7)
  • mBio (7)
  • Biomaterials (6)
  • CELLS (6)
  • Clinical Cancer Research (6)
  • ELIFE (6)
  • Journal of Comparative Neurology (6)
  • Journal of Experimental Medicine (6)
  • Journal of Thrombosis and Haemostasis (6)
  • Journal of the American Heart Association (6)
  • Structure (6)
  • American Journal of Clinical Nutrition (5)
  • BRAIN BEHAVIOR AND IMMUNITY (5)
  • Biological Psychiatry (5)
  • Cancer Research (5)
  • Cell Death and Disease (5)
  • Frontiers in Molecular Neuroscience (5)
  • JOURNAL OF CLINICAL INVESTIGATION (5)
  • Journal of Molecular Biology (5)
  • MOLECULAR BIOLOGY OF THE CELL (5)
  • NEUROBIOLOGY OF DISEASE (5)
  • Neurobiology of Disease (5)
  • Neuroscience (5)
  • Oncogene (5)
  • Vaccine (5)
  • AGING CELL (4)
  • AIDS (4)
  • Antiviral Research (4)
  • Biochemical and Biophysical Research Communications (4)
  • CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (4)
  • CANCERS (4)
  • Cancers (4)
  • Cell Host and Microbe (4)
  • Cytoskeleton (4)
  • Developmental Neurobiology (4)
  • FEBS Letters (4)
  • FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (4)
  • Frontiers in Immunology (4)
  • Genes and Development (4)
  • International Journal of Molecular Sciences (4)
  • Journal of Neurochemistry (4)
  • Journal of Neuroscience Research (4)
  • Kidney International (4)
  • Molecular Psychiatry (4)
  • NUTRIENTS (4)
  • Nature Genetics (4)
  • Nature Neuroscience (4)
  • PNAS (4)
  • Proteomics (4)
  • Science Translational Medicine (4)
  • VACCINES (4)
  • eLife (4)
  • ACS NANO (3)
  • ACTA NEUROPATHOLOGICA COMMUNICATIONS (3)
  • AMERICAN JOURNAL OF TRANSPLANTATION (3)
  • ARTHRITIS & RHEUMATOLOGY (3)
  • Atherosclerosis (3)
  • BIOMOLECULES (3)
  • Biochemical Journal (3)
  • CANCER MEDICINE (3)
  • CELL (3)
  • CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (3)
  • Circulation Research (3)
  • Current Biology (3)

Keyword

  • scienc (1736)
  • biomedicin (1440)
  • life (1440)
  • cell (785)
  • biolog (560)
  • 1 (426)
  • express (385)
  • molecular (376)
  • diseas (338)
  • biochemistri (331)
  • bind (327)
  • activ (321)
  • gene (319)
  • multidisciplinari (298)
  • factor (289)
  • receptor (284)
  • 2 (282)
  • c (277)
  • topic (272)
  • other (271)
  • kinas (233)
  • neurolog (228)
  • neurosci (227)
  • cancer (216)
  • rna (191)
  • virus (181)
  • 3 (179)
  • respons (177)
  • system (164)
  • a (158)
  • in (152)
  • domain (147)
  • alpha (144)
  • medicin (143)
  • infect (142)
  • research (141)
  • oncolog (138)
  • model (137)
  • reactiv (129)
  • dna (128)
  • complex (127)
  • growth (127)
  • b (126)
  • associ (125)
  • immun (124)
  • acid (123)
  • stress (123)
  • structur (120)
  • immunolog (119)
  • transcript (119)
  • beta (117)
  • inflamm (117)
  • virolog (115)
  • human (114)
  • syndrom (113)
  • genet (110)
  • antibodi (109)
  • mice (107)
  • phosphoryl (105)
  • creactiv (104)
  • mous (103)
  • geneexpress (100)
  • microbiolog (100)
  • mutat (100)
  • t (98)
  • regul (97)
  • pathway (96)
  • brain (95)
  • messeng (94)
  • tumor (93)
  • neuron (92)
  • experiment (91)
  • inhibitor (91)
  • signal (91)
  • differenti (89)
  • metabol (88)
  • membran (87)
  • resist (87)
  • transport (87)
  • cardiovascular (86)
  • risk (85)
  • vivo (85)
  • oxid (82)
  • vaccin (82)
  • invivo (81)
  • mechan (81)
  • 4 (80)
  • messengerrna (80)
  • therapi (79)
  • chemistri (78)
  • hered (78)
  • p (78)
  • hiv (77)
  • methyl (76)
  • proteinkinas (76)
  • depend (75)
  • identif (72)
  • interact (72)

Author affiliation

  • Position object (104) (19)
  • Position object (168) (6)
  • Position object (169) (6)
  • Position object (103) (4)
  • Position object (112) (4)
  • Position object (113) (4)
  • Position object (114) (4)
  • Position object (151) (4)
  • Position object (45) (4)
  • Position object (56) (4)
  • Position object (57) (4)
  • Position object (58) (4)
  • School of Medicine: Core Labs (4)
  • Winship Cancer Institute (4)
  • Position object (100) (3)
  • Position object (145) (3)
  • Position object (147) (3)
  • Position object (18) (3)
  • Position object (22) (3)
  • Position object (23) (3)
  • Position object (37) (3)
  • Position object (38) (3)
  • Position object (52) (3)
  • Position object (53) (3)
  • Department of Biomedical Informatics (2)
  • Department of Pathology and Laboratory Medicine (2)
  • Position object (101) (2)
  • Position object (102) (2)
  • Position object (44) (2)
  • Position object (55) (2)
  • Position object (6) (2)
  • Position object (67) (2)
  • The Wallace H. Coulter Department of Biomedical Engineering (2)
  • Baptist Health South Florida (1)
  • Emory + Children's Center (1)
  • Florida international University, Miami (1)
  • Kaiser Permanente of Georgia (1)
  • Position object (116) (1)
  • Position object (138) (1)
  • Position object (139) (1)
  • Position object (140) (1)
  • Position object (144) (1)
  • Position object (158) (1)
  • Position object (159) (1)
  • Position object (43) (1)
  • Position object (60) (1)
  • Position object (61) (1)
  • Position object (78) (1)
  • Position object (83) (1)
  • Secondary Appointment: Department of Pediatrics (1)

Author department

  • Pathology: Admin (217)
  • Biochem: Admin (177)
  • Cell Biology: Admin (129)
  • Pharmacology: Admin (127)
  • Hum Gen: Admin (101)
  • Micro/Immun: Admin (92)
  • BME: Admin (89)
  • Peds: Infectious Disease (81)
  • Medicine: Infectious Dis (78)
  • Peds: Emory LOBP (69)
  • Psych: Admin (61)
  • HMO: Med Onc (59)
  • Medicine: Pulmonary (56)
  • Medicine: Cardiology (55)
  • Epidemiology (52)
  • Neurology: Cog Neurobehav (46)
  • HMO: Hematology (43)
  • Rad Onc: Admin (42)
  • Biostatistics (40)
  • Medicine: Nephrology (39)
  • Psych: Adult (39)
  • Core Labs (34)
  • Chemistry (28)
  • Global Health (28)
  • Environmental Health (27)
  • Winship Cancer Institute (27)
  • Neurology: Movement Disor (26)
  • EVP Health Affairs (25)
  • Medicine: Digestive Dis (25)
  • Medicine: Endocrinology (25)
  • Microbiology & Immunology (24)
  • Ofc Research Fund Supprt (24)
  • Peds: Leukemia Lymphoma (24)
  • Neurosurgery: Admin (20)
  • Ophthal: Admin (18)
  • Peds: Cystic Fibrosis (18)
  • Emory Vaccine Center (17)
  • Anesthesiology: Admin (16)
  • Orthopaedics: Admin (16)
  • Surgery: Transplant (16)
  • Dermatology: Admin (15)
  • Peds: Children's Hrt Ctr (15)
  • Peds: HemThrom (15)
  • Academic Advancement (14)
  • GYN OB: Research (14)
  • Medicine: Admin (13)
  • Neuro-Oncology (13)
  • Biology (12)
  • Physiology: Admin (12)
  • Surgery: Thoracic (12)
  • Hum Gen: Medical Genetics (11)
  • Infectious Disease (11)
  • Peds: General (11)
  • Physics (11)
  • BMI: Admin (10)
  • Peds: Administration (10)
  • Peds: Gastroenterology (10)
  • Surgery: Oncology (10)
  • Peds: Neurology (9)
  • Ctr Study Human Health (8)
  • Medicine: Immunology (8)
  • Neurology: Neuromuscular (8)
  • Neurology: Stroke (8)
  • Sickle Cell (8)
  • Surgery: General (8)
  • Leukemia Lymphoma (7)
  • Rad: MR Research Lab (7)
  • Urology: Admin (7)
  • Dev & Cog Neuroscience (6)
  • GME: Grad Medicine Educ (6)
  • Medicine: Rheumatology (6)
  • NND-Neuroscience (6)
  • Otolaryngology:Admin (6)
  • Peds: Neuro-Oncology (6)
  • Rsch Compl & Reg. Affairs (6)
  • Emerg Med: Admin (5)
  • Gastroenterology (5)
  • HMO: BMT (5)
  • Neurology: Admin (5)
  • Psychology (5)
  • Behav Neuro & Psych Dis (4)
  • Dean's Office (4)
  • Dean's Office Operating F (4)
  • GDBBS MMG (4)
  • Nephrology (4)
  • Peds: Marcus Center (4)
  • SR Hem/Onc Profee (4)
  • GYN OB: VCF 2nd MD (3)
  • Medicine: Geriatrics (3)
  • Medicine: Hospital Med (3)
  • Neurology: Neuropsych (3)
  • Peds: Gene Therapy (3)
  • Psych: Child Psych - CAMP (3)
  • Rehab: Admin (3)
  • Rheumatology (3)
  • BHPMI-WHSC (2)
  • BMT (2)
  • Emory Inst for Drug Disc (2)
  • English (2)
  • HemThrom (2)

Search Results for all work with filters:

  • technolog
  • protein

Work 1-10 of 1736

Sorted by relevance
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. ...
>

Article

Transgenic Expression of Human Lysophosphatidic Acid Receptor LPA(2) in Mouse Intestinal Epithelial Cells Induces Intestinal Dysplasia

by Chang-Hyon Yun; Peijian He; M Yoshida

2016

  • View Abstract

Abstract:Close

Lysophosphatidic acid (LPA) acts on LPA2 receptor to mediate multiple pathological effects that are associated with tumorigenesis. The absence of LPA2 attenuates tumor progression in rodent models of colorectal cancer, but whether overexpression of LPA2 alone can lead to malignant transformation in the intestinal tract has not been studied. In this study, we expressed human LPA2 in intestinal epithelial cells (IECs) under control of the villin promoter. Less than 4% of F1-generation mice had germline transmission of transgenic (TG) human LPA2; as such only 3 F1 mice out of 72 genotyped had TG expression. These TG mice appeared anemic with hematochezia and died shortly after birth. TG mice were smaller in size compared with the wild type mouse of the same age and sex. Morphological analysis showed that TG LPA2 colon had hyper-proliferation of IECs resulting in increased colonic crypt depth. Surprisingly, TG small intestine had villus blunting and decreased IEC proliferation and dysplasia. In both intestine and colon, TG expression of LPA2 compromised the terminal epithelial differentiation, consistent with epithelial dysplasia. Furthermore, we showed that epithelial dysplasia was observed in founder mouse intestine, correlating LPA2 overexpression with epithelial dysplasia. The current study demonstrates that overexpression of LPA2 alone can lead to intestinal dysplasia.

Article

Transgenic Expression of Human Lysophosphatidic Acid Receptor LPA(2) in Mouse Intestinal Epithelial Cells Induces Intestinal Dysplasia

by Chang-Hyon Yun; Peijian He; M Yoshida

2016

  • View Abstract

Abstract:Close

Lysophosphatidic acid (LPA) acts on LPA2 receptor to mediate multiple pathological effects that are associated with tumorigenesis. The absence of LPA2 attenuates tumor progression in rodent models of colorectal cancer, but whether overexpression of LPA2 alone can lead to malignant transformation in the intestinal tract has not been studied. In this study, we expressed human LPA2 in intestinal epithelial cells (IECs) under control of the villin promoter. Less than 4% of F1-generation mice had germline transmission of transgenic (TG) human LPA2; as such only 3 F1 mice out of 72 genotyped had TG expression. These TG mice appeared anemic with hematochezia and died shortly after birth. TG mice were smaller in size compared with the wild type mouse of the same age and sex. Morphological analysis showed that TG LPA2 colon had hyper-proliferation of IECs resulting in increased colonic crypt depth. Surprisingly, TG small intestine had villus blunting and decreased IEC proliferation and dysplasia. In both intestine and colon, TG expression of LPA2 compromised the terminal epithelial differentiation, consistent with epithelial dysplasia. Furthermore, we showed that epithelial dysplasia was observed in founder mouse intestine, correlating LPA2 overexpression with epithelial dysplasia. The current study demonstrates that overexpression of LPA2 alone can lead to intestinal dysplasia.

Article

Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads

by Adam Marcus; Hans Grossniklaus; Hua Yang; I Schmack; L Berglin; X Nie; J Wen; SJ Kang; MJ Lynn; JA Kapp

2009

  • View Abstract

Abstract:Close

Purpose: The study was conducted to create a rapidly developing and reproducible animal model of subretinal choroidal neovascularization (CNV) that allows a time-dependent evaluation of growth dynamics, histopathologic features, and cytokine expression. Methods: C57BL/6 and chemoattractant leukocyte protein-2 deficient (ΔCcl-2) mice were studied. Mice received single or combined subretinal injections of cultured retinal pigment epithelium (RPE; C57BL/ 6-derived), polystyrene microbeads, or phosphate buffer solution (PBS). Fluorescence angiograms were performed over a period of 3 weeks. Mice were euthanized on post inoculation day 3, 7, 10, 14, or 21, and their eyes were evaluated by light, confocal, and electron microscopy. Results: CNV membranes occurred in all study groups with an overall incidence of 94.3%. They extended in the subretinal space through central breaks in Bruch's membrane. CNV lesions were characterized by dynamic changes such as initiation, active inflammatory, and involution stages. CNV thickness peaked around PI day 7 and was greater in mice that received combined injections of RPE and microbeads or RPE cells alone. Small lesions developed in the control groups (microbeads or PBS only), in ΔCcl-2, and old C57BL/6 mice. Variable expression of cytokines and growth factors was detected within the membranes. Conclusions: Our murine model represents a reliable approach inducing CNV growth by subretinal injection of either RPE cells alone or RPE cells and microbeads. The development of CNV lesions is a dynamic process that relies in part on macrophage trafficking and age. © 2009 Molecular Vision.

Chapter

Termination of Transcription of Short Noncoding RNAs by RNA Polymerase II

by Daniel Reines; KM Arndt

2015-01-01

  • View Abstract

Abstract:Close

The RNA polymerase II transcription cycle is often divided into three major stages: initiation, elongation, and termination. Research over the last decade has blurred these divisions and emphasized the tightly regulated transitions that occur as RNA polymerase II synthesizes a transcript from start to finish. Transcription termination, the process that marks the end of transcription elongation, is regulated by proteins that interact with the polymerase, nascent transcript, and/or chromatin template. The failure to terminate transcription can cause accumulation of aberrant transcripts and interfere with transcription at downstream genes. Here, we review the mechanism, regulation, and physiological impact of a termination pathway that targets small noncoding transcripts produced by RNA polymerase II. We emphasize the Nrd1-Nab3-Sen1 pathway in yeast, in which the process has been extensively studied. The importance of understanding small RNA termination pathways is underscored by the need to control noncoding transcription in eukaryotic genomes.

Article

Accounting for the Influence of Inflammation on Retinol Binding Protein in a Population Survey of Liberian Preschool-Aged Children

by Leila Margaret Larson; O. Addo; Fanny Sandalinas; Katherine Faigao; Roland Kupka; Rafael Flores-Ayala; Parminder Suchdev

2015

Subjects
  • Health Sciences, Nutrition
  • File Download
  • View Abstract

Abstract:Close

Vitamin A deficiency (VAD) is an important contributor to child morbidity and mortality. The prevalence of VAD, measured by retinol-binding protein (RBP) or retinol, is overestimated in populations with a high prevalence of inflammation. We aimed to quantify and adjust for the effect of inflammation on VAD prevalence in a nationally representative survey of Liberian children 6 to 35months of age. We compared five approaches to adjust RBP for inflammation and estimate VAD prevalence (defined as RBP<0.7μmol/L): (1) ignoring inflammation; (2) excluding individuals with inflammation (C-reactive protein (CRP) >5mg/L or alpha1-acid glycoprotein (AGP) >1g/)L; (3) multiplying each individual's RBP by an internal correction factor; (4) by an external correction factor; and (5) using regression (corrected RBP=exp(InRBP - β1(lnCRPobs-lnCRPref) - β2(lnAGPobs-lnAGPref)). Corrected RBP was based on a regression model where reference lnCRP and lnAGP were set to the maximum of the lowest decile. The unadjusted prevalence of VAD was 24.7%. Children with elevated CRP and/or AGP had significantly lower RBP concentrations than their apparently healthy peers (geometric mean RBP 0.79μmol/L (95% CI: 0.76, 0.82) vs. 0.95μmol/L (95% CI: 0.92, 0.97), P<0.001). Using approaches 2-5 resulted in a prevalence of VAD of 11.6%, 14.3%, 13.5% and 7.3%, respectively. Depending on the approach, the VAD prevalence is reduced 10-17 percentage points when inflammation is taken into account. Further quantification of the influence of inflammation on biomarkers of vitamin A status from other national surveys is needed to compare and recommend the preferred adjustment approach across populations.

Article

Docosahexaenoic acid prevents palmitate-induced activation of proteolytic systems in C2C12 myotubes

by Myra Woodworth-Hobbs; Matthew B. Hudson; Jill A. Rahnert; Bin Zheng; Harold Franch; Stephen Price

2014

Subjects
  • Chemistry, Biochemistry
  • File Download
  • View Abstract

Abstract:Close

Saturated fatty acids like palmitate contribute to muscle atrophy in a number of conditions (e.g., type II diabetes) by altering insulin signaling. Akt is a key modulator of protein balance that inhibits the FoxO transcription factors (e.g., FoxO3) which selectively induce the expression of atrophy-inducing genes (atrogenes) in the ubiquitin-proteasome and autophagy-lysosome systems. Conversely, omega-3 polyunsaturated fatty acids have beneficial effects on insulin signaling and may preserve muscle mass. In an earlier report, the omega-3 fatty acid docosahexaenoic acid (DHA) protected myotubes from palmitate-induced atrophy; the mechanisms underlying the alterations in protein metabolism were not identified. This study investigated whether DHA prevents a palmitate-induced increase in proteolysis by restoring Akt/FoxO signaling. Palmitate increased the rate of protein degradation, while cotreatment with DHA prevented the response. Palmitate reduced the activation state of Akt and increased nuclear FoxO3 protein while decreasing its cytosolic level. Palmitate also increased the messenger RNAs (mRNAs) of two FoxO3 atrogene targets, the E3 ubiquitin ligase atrogin-1/MAFbx and the autophagy mediator Bnip3. DHA attenuated the effects of palmitate on Akt activation, FoxO3 localization and atrogene mRNAs. DHA, alone or in combination with palmitate and decreased the ratio of LC3B-II:LC3B-I protein as well as the rate of autophagosome formation, as indicated by reduced LC3B-II protein in the presence of 10 mmol/L methylamine, suggesting an independent effect of DHA on the macroautophagy pathway. These data indicate that palmitate induces myotube atrophy, at least in part, by activating multiple proteolytic systems and that DHA counters the catabolic effects of palmitate by restoring Akt/FoxO signaling.

Article

Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis

by Emily L. Blalock; Hsin Chien; Richard D. Dix

2013

Subjects
  • Biology, Microbiology
  • Health Sciences, Opthamology
  • Biology, Cell
  • File Download
  • View Abstract

Abstract:Close

Interleukin-17 (IL-17), a pro-inflammatory cytokine produced by CD4+ Th17 cells, has been associated with the pathogenesis of several autoimmune diseases including uveitis. The fate of IL-17 during HIV/AIDS, however, remains unclear, and a possible role for IL-17 in the pathogenesis of AIDS-related diseases has not been investigated. Toward these ends, we performed studies using a well-established animal model of experimental murine cytomegalovirus (MCMV) retinitis that develops in C57/BL6 mice with retrovirus-induced immunosuppression (MAIDS). After establishing baseline levels for IL-17 production in whole splenic cells of healthy mice, we observed a significant increase in IL-17 mRNA levels in whole splenic cells of mice with MAIDS of 4-weeks (MAIDS-4), 8-weeks (MAIDS-8), and 10-weeks (MAIDS-10) duration. In contrast, enriched populations of splenic CD4+ T cells, splenic macrophages, and splenic neutrophils exhibited a reproducible decrease in levels of IL-17 mRNA during MAIDS progression. To explore a possible role for IL-17 during the pathogenesis of MAIDS-related MCMV retinitis, we first demonstrated constitutive IL-17 expression in retinal photoreceptor cells of uninfected eyes of healthy mice. Subsequent studies, however, revealed a significant decrease in intraocular levels of IL-17 mRNA and protein in MCMV-infected eyes of MAIDS-10 mice during retinitis development. That MCMV infection might cause a remarkable downregulation of IL-17 production was supported further by the finding that systemic MCMV infection of healthy, MAIDS-4, or MAIDS-10 mice also significantly decreased IL-17 mRNA production by splenic CD4+ T cells. Based on additional studies using IL-10 -/- mice infected systemically with MCMV and IL-10 -/- mice with MAIDS infected intraocularly with MCMV, we propose that MCMV infection downregulates IL-17 production via stimulation of suppressor of cytokine signaling (SOCS)-3 and interleukin-10.

Article

Clinical exome sequencing reveals locus heterogeneity and phenotypic variability of cohesinopathies

by Bo Yuan; Juanita Neira Fresneda; Davut Pehlivan; Teresa Santiago-Sim; Xiaofei Song; Jill Rosenfeld; Jennifer E. Posey; Vipulkumar Patel; Weihong Jin; Margaret P. Adam; Emma L. Baple; John Dean; Chin-To Fong; Scott E. Hickey; Louanne Hudgins; Eyby Leon; Suneeta Madan-Khetarpal; Lettie Rawlins; Cecilie F. Rustad; Asbjorg Stray-Pedersen; Kristian Tveten; Olivia Wenger; Jullianne Diaz; Laura Jenkins; Laura Martin; Marianne McGuire; Marguerite Pietryga; Linda Ramsdell; Leah Slattery; Farida Abid; Alison Bertuch; Dorothy Grange; LaDonna Immken; Christian P Schaaf; Hilde Van Esch; Weimin Bi; Sau Wai Cheung; Amy M. Breman; Janice L. Smith; Chad Shaw; Andrew H. Crosby; Christine Eng; Yaping Yang; James R. Lupski; Rui Xiao; Pengfei Liu

2019

Subjects
  • Biology, Genetics
  • Biology, Molecular
  • File Download
  • View Abstract

Abstract:Close

Purpose: Defects in the cohesin pathway are associated with cohesinopathies, notably Cornelia de Lange syndrome (CdLS). We aimed to delineate pathogenic variants in known and candidate cohesinopathy genes from a clinical exome perspective. Methods: We retrospectively studied patients referred for clinical exome sequencing (CES, N = 10,698). Patients with causative variants in novel or recently described cohesinopathy genes were enrolled for phenotypic characterization. Results: Pathogenic or likely pathogenic single-nucleotide and insertion/deletion variants (SNVs/indels) were identified in established disease genes including NIPBL (N = 5), SMC1A (N = 14), SMC3 (N = 4), RAD21 (N = 2), and HDAC8 (N = 8). The phenotypes in this genetically defined cohort skew towards the mild end of CdLS spectrum as compared with phenotype-driven cohorts. Candidate or recently reported cohesinopathy genes were supported by de novo SNVs/indels in STAG1 (N = 3), STAG2 (N = 5), PDS5A (N = 1), and WAPL (N = 1), and one inherited SNV in PDS5A. We also identified copy-number deletions affecting STAG1 (two de novo, one of unknown inheritance) and STAG2 (one of unknown inheritance). Patients with STAG1 and STAG2 variants presented with overlapping features yet without characteristic facial features of CdLS. Conclusion: CES effectively identified disease-causing alleles at the mild end of the cohensinopathy spectrum and enabled characterization of candidate disease genes.

Article

ELMOD2 regulates mitochondrial fusion in a mitofusin-dependent manner, downstream of ARL2

by Cara R. Schiavon; Rachel E. Turn; Laura E. Newman; Richard A Kahn

2019

Subjects
  • Biology, Cell
  • Chemistry, Biochemistry
  • File Download
  • View Abstract

Abstract:Close

Mitochondria are essential and dynamic organelles undergoing constant fission and fusion. The primary players in mitochondrial morphology (MFN1/2, OPA1, DRP1) have been identified, but their mechanism(s) of regulation are still being elucidated. ARL2 is a regulatory GTPase that has previously been shown to play a role in the regulation of mitochondrial morphology. Here we demonstrate that ELMOD2, an ARL2 GTPase-activating protein (GAP), is necessary for ARL2 to promote mitochondrial elongation. We show that loss of ELMOD2 causes mitochondrial fragmentation and a lower rate of mitochondrial fusion, while ELMOD2 overexpression promotes mitochondrial tubulation and increases the rate of fusion in a mitofusin-dependent manner. We also show that a mutant of ELMOD2 lacking GAP activity is capable of promoting fusion, suggesting that ELMOD2 does not need GAP activity to influence mitochondrial morphology. Finally, we show that ELMOD2, ARL2, Mitofusins 1 and 2, Miros 1 and 2, and mitochondrial phospholipase D (mitoPLD) all localize to discrete, regularly spaced puncta along mitochondria. These results suggest that ELMOD2 is functioning as an effector downstream of ARL2 and upstream of the mitofusins to promote mitochondrial fusion. Our data provide insights into the pathway by which mitochondrial fusion is regulated in the cell.

Article

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead

by William H. Goodson, lll; Leroy Lowe; David O. Carpenter; Michael Gilbertson; Abdul Manaf Ali; Adela Lopez de Cerain Salsamendi; Ahmed Lasfar; Amancio Carnero; Amaya Azqueta; Amedeo Amedei; Amelia K. Charles; Andrew R. Collins; Andrew Ward; Anna C. Salzberg; Anna Maria Colacci; Ann -Karin Olsen; Arthur Berg; Barry J. Barclay; Robert Craig Castellino; Rita Nahta

2015

Subjects
  • Health Sciences, Oncology
  • File Download
  • View Abstract

Abstract:Close

Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/ mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety 'Mode of Action' framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology.
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. ...
>
Site Statistics
  • 33,714
  • Total Works
  • 7,934,812
  • Downloads
  • 551,751
  • Downloads This Year

Copyright © 2016 Emory University - All Rights Reserved
540 Asbury Circle, Atlanta, GA 30322-2870
(404) 727-6861
Privacy Policy | Terms & Conditions

v2.2.8-dev

Contact Us
Download now